Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
2.87
Dollar change
+0.09
Percentage change
3.24
%
Index- P/E- EPS (ttm)-0.41 Insider Own64.22% Shs Outstand25.63M Perf Week19.58%
Market Cap74.42M Forward P/E- EPS next Y-0.55 Insider Trans0.00% Shs Float9.28M Perf Month3.24%
Income-10.49M PEG- EPS next Q-0.12 Inst Own28.07% Short Float0.05% Perf Quarter10.38%
Sales0.00M P/S- EPS this Y5.67% Inst Trans45.52% Short Ratio0.58 Perf Half Y-12.50%
Book/sh0.25 P/B11.47 EPS next Y-24.06% ROA-86.04% Short Interest0.00M Perf Year-6.82%
Cash/sh0.26 P/C11.21 EPS next 5Y- ROE-95.37% 52W Range1.62 - 4.05 Perf YTD18.60%
Dividend Est.- P/FCF- EPS past 5Y- ROI-161.73% 52W High-29.14% Beta-1.01
Dividend TTM- Quick Ratio6.73 Sales past 5Y0.00% Gross Margin- 52W Low77.16% ATR (14)0.20
Dividend Ex-Date- Current Ratio6.73 EPS Y/Y TTM7.26% Oper. Margin0.00% RSI (14)62.04 Volatility6.96% 7.20%
Employees2 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q29.40% Payout- Rel Volume0.49 Prev Close2.78
Sales Surprise- EPS Surprise-10.00% Sales Q/Q- EarningsFeb 13 AMC Avg Volume7.96K Price2.87
SMA209.87% SMA5010.65% SMA20012.90% Trades Volume3,912 Change3.24%
Feb-13-24 04:05PM
Nov-14-23 04:05PM
Oct-19-23 09:40AM
Oct-06-23 04:06PM
04:06PM
09:40AM Loading…
Oct-03-23 09:40AM
Sep-21-23 10:06AM
Sep-20-23 04:29PM
Aug-30-23 08:00AM
Aug-22-23 09:37AM
Aug-21-23 08:00AM
Aug-15-23 10:20AM
Jun-12-23 09:40AM
May-30-23 08:33AM
May-24-23 09:40AM
09:35AM Loading…
May-19-23 09:35AM
May-11-23 08:00AM
Mar-28-23 08:00AM
Mar-08-23 08:00AM
Feb-14-23 09:30AM
Feb-10-23 08:38AM
Jan-09-23 08:00AM
Dec-21-22 05:42AM
Nov-10-22 08:00AM
Nov-01-22 04:00PM
Sep-26-22 08:56AM
07:00AM
07:00AM
Sep-20-22 08:00AM
Sep-09-22 08:00AM
05:00PM Loading…
Aug-23-22 05:00PM
Aug-16-22 03:00PM
Jul-14-22 06:23AM
Jul-05-22 07:57AM
06:00AM
Jun-23-22 04:00PM
May-24-22 04:00PM
May-11-22 09:00AM
Apr-01-22 07:00AM
Feb-11-22 08:00AM
Feb-04-22 04:30AM
Jan-06-22 07:00AM
07:00AM
Jan-04-22 07:00AM
Jan-03-22 07:00AM
Nov-12-21 08:00AM
Oct-13-21 08:00AM
Oct-12-21 08:59AM
Oct-05-21 08:00AM
Sep-27-21 07:41AM
Sep-22-21 04:05PM
Sep-20-21 08:13AM
Sep-13-21 08:00AM
08:00AM
Sep-07-21 08:00AM
07:04AM
Aug-23-21 08:31AM
Aug-16-21 08:39AM
Aug-12-21 08:00AM
Aug-09-21 08:01AM
Aug-08-21 03:23AM
Aug-03-21 02:40PM
Jul-26-21 08:02AM
Jul-12-21 08:22AM
Jun-21-21 04:05PM
May-06-21 08:00PM
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.